SCHEMBL3174346

SCHEMBL3174346

CC(=O)NCCNc1cc(NCCNC(=O)c2cccc(C)c2)nc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 2/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ADORA2A P29274 1/20 0.48
ADORA1 P30542 1/20 0.48
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CLK4 Q9HAZ1 3/20 0.47
MAPK1 P28482 2/20 0.47
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
POLB P06746 3/20 0.46
MAPT P10636 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
CYP2D6 P10635 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163394 0.91 ADORA1 (0.51) ALDH1A1KDM4ELMNAKMT2AADORA2A
SCHEMBL3163147 0.90 ALDH1A1 (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3165176 0.89 POLB (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3175889 0.88 ADORA2A (0.58) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3161464 0.88 L3MBTL1 (0.53) NPC1RAB9AALDH1A1KDM4ELMNA
SCHEMBL3168745 0.87 ADORA2A (0.56) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL3162824 0.86 ADORA1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3170555 0.85 CYP1A2 (0.61) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL3162869 0.85 ALDH1A1 (0.55) ALDH1A1LMNACYP1A2CYP3A4CLK4
SCHEMBL3168663 0.85 ADORA1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed